I think it will be earlier than that. The last patient completed the 6 week trial on 1st-Jul in the UK (refer to the announcement on 2nd-Jul). The 4 week follow-up was last night our time for that patient. So technically the data can be unblinded as of today. They’ve already completed a blinded analysis of the data so they’ll have a pretty good jump start once they unblind it. Will probably come down to availability of the DSMB. But I was expecting results to be announced next week.
EU regulators reject Leqembi for Alzheimers, page-24
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.57M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.7¢ | 2.5¢ | $59.07K | 2.276M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2152913 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 6707443 | 10 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |